Declan Doogan - 01 Jul 2025 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Issuer symbol
TENX
Transactions as of
01 Jul 2025
Net transactions value
$0
Form type
4
Filing time
03 Jul 2025, 08:12:14 UTC
Previous filing
12 Dec 2024
Next filing
13 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doogan Declan Director 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL /s/ S. Halle Vakani, as Attorney-in-Fact 03 Jul 2025 0001704234

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TENX Common Stock 2,274 01 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TENX Stock Option (right to buy) Award $0 +80,000 $0.000000 80,000 01 Jul 2025 Common Stock 80,000 $5.75 Direct
holding TENX Stock Option (right to buy) 4 01 Jul 2025 Common Stock 4 $3200.00 Direct
holding TENX Stock Option (right to buy) 4 01 Jul 2025 Common Stock 4 $992.00 Direct
holding TENX Stock Option (right to buy) 100,000 01 Jul 2025 Common Stock 100,000 $5.94 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.